Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165.5 USD | -1.32% | +0.79% | -7.95% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.95% | 9.37B | |
-4.66% | 185B | |
-1.01% | 109B | |
-4.20% | 68.54B | |
+2.68% | 51.74B | |
+9.12% | 45.22B | |
+3.12% | 41.74B | |
+4.13% | 26.83B | |
+3.31% | 26.69B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing